IDEX (IEX) Beat Estimates And Landed Record Orders, Is It Still Below Fair Value?

IDEX (IEX) stock activity in August has been shaped more by the company’s strong second quarter than by boardroom news. Investors are weighing record orders above US$1b, alongside a recent director resignation.

Over the past year, IDEX’s share price has risen strongly, with a year to date share price return of 28.6% and a 1 year total shareholder return of 42.07%. This suggests momentum has been building as investors react more to the second quarter earnings beat and record US$1b plus order book than to the recent board change.

Compare IDEX's recent earnings driven momentum with other industrials by scanning our hand picked list of solid balance sheet and fundamentals (52 results), which may appeal if you value resilient operations and financial strength.

Bulls argue IDEX’s record US$1b plus order book and earnings beat support the higher share price. Bears worry recent gains already reflect that progress. The key question is which side the current valuation appears to support next.

Most Popular Narrative: 9.5% Undervalued

The most followed narrative on IDEX pegs fair value at $254.50 compared with the last close at $230.28. This frames today’s optimism around Q2 and the order book in valuation terms.

The analysts have a consensus price target of $254.5 for IDEX based on their expectations of its future earnings growth, profit margins and other risk factors.

However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $280.0, and the most bearish reporting a price target of just $215.0.

Read the complete narrative. Read the complete narrative.

Want to see what sits behind that fair value gap for IDEX? The story describes revenue trends, changes in margins and the evolving earnings profile. Curious which specific earnings and cash flow paths would need to materialise to justify $254.50? The full narrative lays out those assumptions step by step.

Result: Fair Value of $254.50 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, IDEX investors still need to watch for tariff driven cost pressures and weaker demand in sectors like semiconductors or agriculture, as these factors could unsettle the current narrative.

Find out about the key risks to this IDEX narrative.

Another View on IDEX valuation

The SWS DCF model values IDEX at $277.37 a share, compared with the current price of $230.28. That implies the stock trades at a discount based on modelled future cash flows, which contrasts with an earnings multiple that looks full today. Which signal carries more weight for you right now?

Look into how the SWS DCF model arrives at its fair value.

Next Steps

If the mix of optimism and caution around IDEX leaves you uncertain, quickly review and test the numbers and assumptions yourself. Then consider the potential benefits discussed in our 3 key rewards

Looking for more investment ideas beyond IDEX?

If IDEX has sharpened your focus, do not stop here. Use the Simply Wall St screener to spot more opportunities that fit your approach before others move first.

• Target potential mispriced quality by reviewing companies flagged in the 45 high quality undervalued stocks.
• Prioritise resilience and capital strength with the list of solid balance sheet and fundamentals (52 results).
• Unearth fresh ideas that the market may be overlooking through the 19 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com